Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease
Cells · 2026
DOI: 10.3390/cells15211946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Sean Michael Carr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Indican, Actins, Renal Insufficiency, Chronic, Vascular Remodeling. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nature Science Foundation of China, Tianjin Key Medical Discipline Construction Project, American Heart Association.
Abstract (Originalsprache)
Objective
Chronic kidney disease (CKD) worsens outcomes of peripheral artery diseases (PADs), partly through impaired vascular regeneration and microvascular remodeling. CKD promotes the accumulation of uremic toxins, but their contributions to microvascular dysfunction remain poorly understood. This study investigated the effects of uremic toxin indoxyl sulfate (IS) on vascular smooth muscle cell (VSMC) function and microvascular remodeling in a mouse model of CKD.
Methods
C57BL6/J mice were fed 0.25% adenine diet for 10 days to induce CKD. CKD mice underwent hindlimb ligation surgery. VSMC migration assays, microscopy, and Western blotting were utilized to elucidate the underlying mechanisms underlying the IS-induced impairment of vascular remodeling.
Results
CKD mice exhibited significantly impaired blood flow restoration (44.7% relative blood flow) compared with controls (82.6% relative blood flow) accompanied by a reduced α-smooth muscle expression and decreased formation of smooth muscle-covered micro vessels in ischemic limbs. Wound healing and transwell migrations assays demonstrated IS significantly reduced VSMC motility. IS-exposure also disrupted actin cytoskeletal organization, impaired cell attachment, reduced cell size, and decreased focal adhesion formation. Mechanistically, IS reduced focal adhesion kinase (FAK) expression, impairing VSMC adhesion and migration. Reduced FAK signaling was associated with decreased N-WASP expression and suppression of the Arp2/3 complex, which regulates actin polymerization and cytoskeletal remodeling. These alterations suggest that IS disrupts the cellular processes required for VSMC recruitment and structural remodeling of the microvascular, potentially limiting vessel maturation and stabilization during ischemic recovery.
Conclusions
IS impairs VSMC migration and cytoskeletal organization through the disruption of the FAK-N-WASP-Arp2/3 signaling axis, contributing to defective microvascular remodeling and impaired perfusion recovery in CKD-associated PAD. These findings identify uremic toxin-mediated cytoskeletal dysfunction as a potential therapeutic target for improving microvascular regeneration and vascular recovery in patients with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA 30303, USA.
- Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
ORCID-Profile: Ming-Hui Zou
Förderung
- Nature Science Foundation of China
- Tianjin Key Medical Discipline Construction Project
- American Heart Association
Zitieren
APA
Carr, S. M., Ramprasath, T., & Zou, M. H. (2026). Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease. Cells. https://doi.org/10.3390/cells15211946
Vancouver
Carr SM, Ramprasath T, Zou MH. Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease. Cells. 2026. doi:10.3390/cells15211946
BibTeX
@article{Carr2026,
author = {Carr, Sean Michael and Ramprasath, Tharmarajan and Zou, Ming-Hui},
title = {Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15211946}
}
EUVIMED